APG Asset Management US’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-52,382
Closed -$4.72M 129
2025
Q3
$4.72M Hold
52,382
0.03% 78
2025
Q2
$4.29M Hold
52,382
0.03% 78
2025
Q1
$4.56M Hold
52,382
0.04% 72
2024
Q4
$5.21M Sell
52,382
-25,877
-33% -$2.67M 0.04% 68
2024
Q3
$8.98M Sell
78,259
-972,227
-93% -$116M 0.06% 56
2024
Q2
$134M Buy
1,050,486
+35,627
+4% +$4.59M 0.77% 26
2024
Q1
$133M Buy
1,014,859
+336,836
+50% +$41.5M 0.77% 26
2023
Q4
$73.9M Buy
+678,023
New +$70.4M 0.45% 31

Other funds holding MRK

APG Asset Management US's MRK Position: Q4 2025 in Review

APG Asset Management US sold out of Merck (MRK) in Q4 2025, closing a stake of 52,382 shares — an estimated $4.72M sold.

APG Asset Management US first reported a position in MRK in Q4 2023 and held it in 8 quarters. The position peaked at $134M in Q2 2024. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • APG Asset Management US reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 52,382 Merck shares in Q4 2025, an estimated $4.72M.
  • APG Asset Management US first reported a position in Merck in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Merck position peaked at $134M in Q2 2024.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.